In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity
Authors: Szeląg M., Sikorski K., Czerwoniec A., Szatkowska K., Wesoły J., Bluyssen H.A.R.
Published in: European Journal of Pharmacology
Publication type: article
Subject areas: Pharmacology, Toxicology and Pharmaceutics
SJR best quartile: Q1